Admedus Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.06 |
Market Cap |
$58.99 M |
Shares Outstanding |
352.89 M |
Public Float |
- |
Admedus Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.08 |
Market Cap |
AUD35.4 M |
Shares Outstanding |
589.94 M |
Public Float |
538.98 M |
Address |
9 Sherwood Road Toowong Queensland (QLD) 4066 Australia |
Employees | - |
Website | http://www.admedus.com |
Updated | 07/08/2019 |
Admedus Ltd. engages in the development, commercialization, and distribution of medical products and technologies. It operates through the following segments: Disposable Medical Products and Medical Services Distribution, Bio Implant Operations, Regenerative Medicine Research and Development (R&D), Immunotherapies R&D. The comapny also offers tissue engineering, CardioCel, and other medical products. |